About Nuclear Medicine
Nuclear medicine is a specialty branch of medical imaging that involves the use of modalities such as SPECT and PET scans. These technologies help detect and evaluate various disorders in the areas of oncology, cardiology, and neurology. Modalities for nuclear medicine involve the use of a minimal amount of radioisotopes that are either injected, swallowed, or inhaled by an individual. These radioisotopes reach the specific organ targeted by the pharmaceutical compound and emit radiations that can be detected using a scanner or a detector.
Technavio’s analysts forecast the global nuclear medicine market to grow at a CAGR of 8.34% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global nuclear medicine market for 2016-2020. To calculate the market size, the report considers the use revenue generated from the sales of various types of imaging equipment and radiopharmaceuticals that are used for diagnosis and therapeutic purposes.
The market is divided into the following segments based on geography:
• Americas
• EMEA
• APAC
Technavio's report, Global Nuclear Medicine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Cardinal Health
• Digirad
• GE Healthcare
• Lantheus Medical Imaging
• Philips Healthcare
Other prominent vendors
• ABT Molecular Imaging
• Advanced Accelerator Applications
• AGFA Healthcare
• Algeta
• Astellas Pharma
• Bayer
• Bracco Imaging
• Brain Biosciences
• Capintec
• CMR Naviscan
• Cubresa
• Eczacibasi-Monrol Nuclear Products
• FUJIFILM Holdings
• IBA Molecular Imaging
• ISOLOGIC Innovative Radiopharmaceuticals
• Jubilant DraxImage
• Mallinckrodt
• Mediso Medical Imaging System
• Mirada Medical
• Navidea Biopharmaceuticals
• Nordion
• Piramal Imaging
• Positron Pharmaceutical Company
• RadioMedix
• SHINE Medical Technologies
• Sophie Biosciences
• Toshiba Medical Systems
• Triad Isotopes
• Voxel
Market driver
• Growing demand for radiopharmaceuticals
• For a full, detailed list, view our report
Market challenge
• High cost of nuclear medicine and time constraints owing to its short half-life
• For a full, detailed list, view our report
Market trend
• Partnerships for development of nuclear medicine
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Global nuclear medicine equipment market
• Global SPECT market
• Global PET market
• Global radiopharmaceuticals market
PART 07: Market segmentation by application
• Oncology
• Cardiology
• Neurology
PART 08: Market segmentation by end-user
• Diagnostic centers
• Hospitals
• Research centers
PART 09: Geographical segmentation
• Global nuclear medicine market in Americas
• Reimbursement of radiopharmaceuticals in US
• Global nuclear medicine market in EMEA
• Global nuclear medicine market in APAC
PART 10: Market drivers
• High demand for SPECT and PET imaging
• Rising incidence of cancer and CVDs
• Growing demand for radiopharmaceuticals
PART 11: Impact of drivers
PART 12: Market challenges
• High cost of nuclear medicine and time constraints owing to its short half-life
• Shortage of nuclear medicine
• Regulatory hurdles
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Partnerships for development of nuclear medicine
• Production based on cyclotron
• Growing funding for R&D
PART 15: Vendor landscape
• Competitive scenario
PART 16: Key vendors
• Cardinal Health
• Digirad
• GE Healthcare
• Lantheus Medical Imaging
• Philips Healthcare
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Radioisotopes used in medical imaging
Exhibit 03: Global nuclear medicine market 2015-2020 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global nuclear medicine market segmentation by product
Exhibit 06: Global nuclear medicine market segmentation by product 2015
Exhibit 07: Global nuclear medicine market segmentation by product 2020
Exhibit 08: Global nuclear medicine equipment market 2015-2020 ($ billions)
Exhibit 09: Global SPECT market 2015-2020 ($ billions)
Exhibit 10: Global PET market 2015-2020 ($ millions)
Exhibit 11: Global radiopharmaceuticals market 2015-2020 ($ billions)
Exhibit 12: Global nuclear medicine market segmentation by application 2015
Exhibit 13: Global nuclear medicine market segmentation by end-user 2015
Exhibit 14: Global nuclear medicine market segmentation by geography 2015
Exhibit 15: Global nuclear medicine market segmentation by geography 2020
Exhibit 16: Global nuclear medicine market segmentation by geography 2015-2020
Exhibit 17: Global nuclear medicine market segmentation by geography 2015-2020 ($ billions)
Exhibit 18: Conditions diagnosed using nuclear medicine (in the US)
Exhibit 19: Nuclear medicine market in Americas 2015-2020 ($ billions)
Exhibit 20: Components for Medicare reimbursement
Exhibit 21: Difference in Medicare based on hospital facility and physician's offices
Exhibit 22: Reimbursement provided by Medicare for various nuclear medicines 2015
Exhibit 23: Nuclear medicine market in EMEA 2015-2020 ($ billions)
Exhibit 24: Nuclear medicine market in APAC 2015-2020 ($ millions)
Exhibit 25: Impact of drivers
Exhibit 26: Impact of drivers and challenges
Exhibit 27: Cardinal Health: Product portfolio
Exhibit 28: Cardinal Health: Key takeaways
Exhibit 29: Digirad: Business segmentation by revenue 2015
Exhibit 30: Digirad: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 31: Digirad: Key takeaways
Exhibit 32: GE Healthcare: Product portfolio
Exhibit 33: GE Healthcare: Key takeaways
Exhibit 34: Lantheus Medical Imaging: Product portfolio
Exhibit 35: Regulatory product approvals
Exhibit 36: Lantheus Medical Imaging: Product segmentation by revenue 2015
Exhibit 37: Lantheus Medical Imaging: Product segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 38: Lantheus Medical Imaging: Key takeaways
Exhibit 39: Philips Healthcare: Product portfolio
Exhibit 40: Philips Healthcare: Key takeaways
Exhibit 41: Other prominent vendors
